Novavax, Inc. (NVAX)
8.83
+0.19
(+2.20%)
USD |
NASDAQ |
Apr 17, 16:00
8.90
+0.07
(+0.79%)
After-Hours: 17:14
Novavax EPS Diluted (Quarterly) : 0.1061 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| Moderna, Inc. | -2.107 |
| Intellia Therapeutics, Inc. | -0.8263 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.53M |
| Revenue (Quarterly) | 147.14M |
| Total Expenses (Quarterly) | 129.61M |
| Enterprise Value | 939.85M |
| Gross Profit Margin (Quarterly) | 82.87% |
| Profit Margin (Quarterly) | 11.91% |
| Earnings Yield | 26.96% |
| Operating Earnings Yield | 37.40% |
| Normalized Earnings Yield | 33.58 |